Skip to content
Head to head

GoodRx vs Veeva Systems

Side-by-side on the measures that matter, with a plain-English read. Full detail: GDRX · VEEV

Updated 10 minutes ago

1-year performance, rebased to 100

GDRX +2.5%VEEV -3.9%
Veeva Systems edges it on the scoreable measures. Veeva Systems trades cheapest on trailing earnings; Veeva Systems earns the most per share.
GDRXVEEV
Snapshot
SectorHealth Information ServicesHealth Information Services
Last price2.92266.22
Change today-3.31%+1.26%
1-year return+11.5%-1.6%
Market cap$996.14M$43.10B
52-week range1.77 – 3.89148.05 – 325.99
Valuation
P/E (TTM)48.6743.64
P/E percentile, own 5-yr range80th14th
P/B1.545.80
Dividend yield0.00%0.00%
Profitability & growth
EPS (TTM)0.095.44
Net profit (TTM)$30.70M$880.78M
Revenue (TTM)$785.23M$3.46B
Provider revenue period date2026-06-292026-07-30
Revenue growth (YoY)-1.3%+17.6%
Gross margin90.8%75.0%
Operating margin9.5%29.9%
Net margin2.1%29.3%
Free cash flow (TTM)$131.70M$1.67B
Provider cash-flow period date2026-06-292026-07-30
Ownership & sentiment
Institutional ownership45.3%88.0%
Insider activity (12mo)29 buy / 15 sell25 buy / 22 sell
Short interest (% of float)1.0%2.4%
Analyst consensus100% sell (1)74% buy / 22% hold / 4% sell (23)
Analyst price target$3 (-9%)$320 (+20%)
StockVane view
StockVane Quant RatingC (51)C (37)
Company
Employees6977,928
Founded20112007

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.